Mesoblast Limited (AU:MSB) has released an update.
Mesoblast Limited announces a change in leadership as Joseph R. Swedish steps down as Chair, with Jane Bell AM taking over the role. The company expresses gratitude to Swedish for guiding Mesoblast through a pivotal phase towards its first product commercialization. Bell brings extensive experience in corporate finance and healthcare to the position, as Mesoblast continues to develop its cellular medicine technology for inflammatory diseases.
For further insights into AU:MSB stock, check out TipRanks’ Stock Analysis page.
